My Quote Request
No products added yet
6505-01-068-3545
20 Products
NDC00140-0071-14
CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505010683545
NSN
6505-01-068-3545
NDC00140-0071-14
CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505010683545
NSN
6505-01-068-3545
MFG
HOFFMANN-LA ROCHE INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS AMITRIPTYLINE HYDROCHLORIDE ACTIVE INGREDIENT AND 10.000 MILLIGRAMS CHLORDIAZEPOXIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00338-0481-98
FAT EMULSION INJECTION
NSN, MFG P/N
6505010674822
NSN
6505-01-067-4822
NDC00338-0481-98
FAT EMULSION INJECTION
NSN, MFG P/N
6505010674822
NSN
6505-01-067-4822
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.250 PERCENTAGE, V/V GLYCERIN ACTIVE INGREDIENT AND 10.000 PERCENTAGE, V/V SOYBEAN OIL ACTIVE INGREDIENT AND 1.200 PCT W/V EGG YOLK PHOSPHOLIPIDS ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: W/INTRAVENOUS INJECTION SET
Related Searches:
TRAVAMULSION 10 PCT
FAT EMULSION INJECTION
NSN, MFG P/N
6505010674822
NSN
6505-01-067-4822
TRAVAMULSION 10 PCT
FAT EMULSION INJECTION
NSN, MFG P/N
6505010674822
NSN
6505-01-067-4822
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.250 PERCENTAGE, V/V GLYCERIN ACTIVE INGREDIENT AND 10.000 PERCENTAGE, V/V SOYBEAN OIL ACTIVE INGREDIENT AND 1.200 PCT W/V EGG YOLK PHOSPHOLIPIDS ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: W/INTRAVENOUS INJECTION SET
Related Searches:
15902PX
MAGNESIUM SULFATE INJECTION,USP
NSN, MFG P/N
6505010674849
NSN
6505-01-067-4849
15902PX
MAGNESIUM SULFATE INJECTION,USP
NSN, MFG P/N
6505010674849
NSN
6505-01-067-4849
MFG
INVENEX LABORATORIES LIFE TECHNOLOGIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 PERCENTAGE, W/V MAGNESIUM SULFATE ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 2 ML. IN A 6 ML. PARTIAL FILL SINGLE DOSE VIAL WITH FLIP-OFF TOP; MUST BE DILUTED BEFORE INTRAVENOUS USE
Related Searches:
NDC00467-0159-25
MAGNESIUM SULFATE INJECTION,USP
NSN, MFG P/N
6505010674849
NSN
6505-01-067-4849
NDC00467-0159-25
MAGNESIUM SULFATE INJECTION,USP
NSN, MFG P/N
6505010674849
NSN
6505-01-067-4849
MFG
INVENEX LABORATORIES LIFE TECHNOLOGIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 PERCENTAGE, W/V MAGNESIUM SULFATE ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 2 ML. IN A 6 ML. PARTIAL FILL SINGLE DOSE VIAL WITH FLIP-OFF TOP; MUST BE DILUTED BEFORE INTRAVENOUS USE
Related Searches:
NDC00093-0262-15
FLUOCINONIDE CREAM,USP
NSN, MFG P/N
6505010674850
NSN
6505-01-067-4850
NDC00093-0262-15
FLUOCINONIDE CREAM,USP
NSN, MFG P/N
6505010674850
NSN
6505-01-067-4850
MFG
LEMMON CO
Description
ACTIVE INGREDIENT AND STRENGTH: 0.050 FLUOCINONIDE PERCENTAGE, W/W
ADMINISTRATION: TOPICAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLUOCINONIDE CREAM USP 15GM TUBE
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
SPECIAL FEATURES: WATER WASHABLE,AQUEOUS MINERAL OIL BASE
Related Searches:
NDC49158-0212-20
FLUOCINONIDE CREAM,USP
NSN, MFG P/N
6505010674850
NSN
6505-01-067-4850
NDC49158-0212-20
FLUOCINONIDE CREAM,USP
NSN, MFG P/N
6505010674850
NSN
6505-01-067-4850
MFG
THAMES PHARMACAL CO INC
Description
ACTIVE INGREDIENT AND STRENGTH: 0.050 FLUOCINONIDE PERCENTAGE, W/W
ADMINISTRATION: TOPICAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLUOCINONIDE CREAM USP 15GM TUBE
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
SPECIAL FEATURES: WATER WASHABLE,AQUEOUS MINERAL OIL BASE
Related Searches:
HYDERGINE TABLETS
ERGOLOID MESYLATES TABLETS,USP
NSN, MFG P/N
6505010675324
NSN
6505-01-067-5324
HYDERGINE TABLETS
ERGOLOID MESYLATES TABLETS,USP
NSN, MFG P/N
6505010675324
NSN
6505-01-067-5324
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.333 MILLIGRAMS DIHYDROERGOCORNINE MESYLATE ACTIVE INGREDIENT AND 0.333 MILLIGRAMS DIHYDROERGOCRISTINE MESYLATE ACTIVE INGREDIENT AND 0.333 MILLIGRAMS DIHYDROERGOCRYPTINE MESYLATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ERGOLOID MESYLATES TABLETS USP 1 MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: TOTAL 1 MG
Related Searches:
NDC00078-0070-05
ERGOLOID MESYLATES TABLETS,USP
NSN, MFG P/N
6505010675324
NSN
6505-01-067-5324
NDC00078-0070-05
ERGOLOID MESYLATES TABLETS,USP
NSN, MFG P/N
6505010675324
NSN
6505-01-067-5324
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.333 MILLIGRAMS DIHYDROERGOCORNINE MESYLATE ACTIVE INGREDIENT AND 0.333 MILLIGRAMS DIHYDROERGOCRISTINE MESYLATE ACTIVE INGREDIENT AND 0.333 MILLIGRAMS DIHYDROERGOCRYPTINE MESYLATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ERGOLOID MESYLATES TABLETS USP 1 MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: TOTAL 1 MG
Related Searches:
NDC00536-3856-01
ERGOLOID MESYLATES TABLETS,USP
NSN, MFG P/N
6505010675324
NSN
6505-01-067-5324
NDC00536-3856-01
ERGOLOID MESYLATES TABLETS,USP
NSN, MFG P/N
6505010675324
NSN
6505-01-067-5324
MFG
RUGBY GROUP INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.333 MILLIGRAMS DIHYDROERGOCORNINE MESYLATE ACTIVE INGREDIENT AND 0.333 MILLIGRAMS DIHYDROERGOCRISTINE MESYLATE ACTIVE INGREDIENT AND 0.333 MILLIGRAMS DIHYDROERGOCRYPTINE MESYLATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ERGOLOID MESYLATES TABLETS USP 1 MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: TOTAL 1 MG
Related Searches:
ALM11778
INFLUENZA VIRUS VACCINE,USP
NSN, MFG P/N
6505010679533
NSN
6505-01-067-9533
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ADSORBENT: ANY ACCEPTABLE
ADSORBENT MATERIAL: ANY ACCEPTABLE
DESIGN CONTROL REFERENCE: ALM11778
IMMEDIATE CONTAINER QUANTITY: 1
IMMEDIATE CONTAINER TYPE: BOTTLE
MANUFACTURERS CODE: 89875
QUANTITY WITHIN EACH IMMEDIATE CONTAINER: 10 DOSES
SPECIAL FEATURES: SPLIT VIRUS ONLY; 0.5 ML PER DOSE; FOR NON-MILITARY PERSONS 6 MONTHS TO 25 YEARS OF AGE
THE MANUFACTURERS DATA:
VALENCE: POLYVALENT
VIRUS STRAIN: A/USSR STRAIN 20 UG MINIMUM HEMAGGLUTININ PER DOSE; A/TEXAS STRAIN 7 UG MINIMUM HEMAGGLUTININ PER DOSE; B/HONG KONG STRAIN 7 UG MINIMUM HEMAGGLUTININ PER DOSE
Related Searches:
2A6433
AMINO ACIDS INJECTION WITH ELECTROLYTES
NSN, MFG P/N
6505010679753
NSN
6505-01-067-9753
2A6433
AMINO ACIDS INJECTION WITH ELECTROLYTES
NSN, MFG P/N
6505010679753
NSN
6505-01-067-9753
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 8.500 PERCENTAGE,W/V AMINO ACIDS ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINO ACIDS INJECTION WITH ELECTROLYTES 8.5% 500ML 12S BT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: NONPYROGENIC,HYPERTONIC
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
AMINOSYN
AMINO ACIDS INJECTION WITH ELECTROLYTES
NSN, MFG P/N
6505010679753
NSN
6505-01-067-9753
AMINOSYN
AMINO ACIDS INJECTION WITH ELECTROLYTES
NSN, MFG P/N
6505010679753
NSN
6505-01-067-9753
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 8.500 PERCENTAGE,W/V AMINO ACIDS ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINO ACIDS INJECTION WITH ELECTROLYTES 8.5% 500ML 12S BT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: NONPYROGENIC,HYPERTONIC
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00074-5856-03
AMINO ACIDS INJECTION WITH ELECTROLYTES
NSN, MFG P/N
6505010679753
NSN
6505-01-067-9753
NDC00074-5856-03
AMINO ACIDS INJECTION WITH ELECTROLYTES
NSN, MFG P/N
6505010679753
NSN
6505-01-067-9753
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 8.500 PERCENTAGE,W/V AMINO ACIDS ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINO ACIDS INJECTION WITH ELECTROLYTES 8.5% 500ML 12S BT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: NONPYROGENIC,HYPERTONIC
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00338-0459-03
AMINO ACIDS INJECTION WITH ELECTROLYTES
NSN, MFG P/N
6505010679753
NSN
6505-01-067-9753
NDC00338-0459-03
AMINO ACIDS INJECTION WITH ELECTROLYTES
NSN, MFG P/N
6505010679753
NSN
6505-01-067-9753
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 8.500 PERCENTAGE,W/V AMINO ACIDS ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINO ACIDS INJECTION WITH ELECTROLYTES 8.5% 500ML 12S BT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: NONPYROGENIC,HYPERTONIC
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
TRAVASOL
AMINO ACIDS INJECTION WITH ELECTROLYTES
NSN, MFG P/N
6505010679753
NSN
6505-01-067-9753
TRAVASOL
AMINO ACIDS INJECTION WITH ELECTROLYTES
NSN, MFG P/N
6505010679753
NSN
6505-01-067-9753
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 8.500 PERCENTAGE,W/V AMINO ACIDS ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINO ACIDS INJECTION WITH ELECTROLYTES 8.5% 500ML 12S BT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: NONPYROGENIC,HYPERTONIC
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
5647-25
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505010683308
NSN
6505-01-068-3308
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 70.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROSE INJECTION USP 70% DEXTROSE 500ML 6S GLASS BT
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ABBOTT LABS
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, GLASS
SPECIAL FEATURES: PARTIAL FILL 500 ML IN 1000 ML I.V. BOTTLE; FOR DILUTION
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
NDC00074-5647-25
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505010683308
NSN
6505-01-068-3308
NDC00074-5647-25
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505010683308
NSN
6505-01-068-3308
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 70.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROSE INJECTION USP 70% DEXTROSE 500ML 6S GLASS BT
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ABBOTT LABS
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, GLASS
SPECIAL FEATURES: PARTIAL FILL 500 ML IN 1000 ML I.V. BOTTLE; FOR DILUTION
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
NDC00472-1467-16
DETERGENT,SURGICAL
NSN, MFG P/N
6505010683543
NSN
6505-01-068-3543
MFG
NATIONAL PHARMACEUTICAL MFG CO A DIV OF BARRE-NATIONAL INC SUB OF REVCO D S INC
Description
INGREDIENT CLASSIFICATION: MEDICATED
QUANTITY WITHIN EACH UNIT PACKAGE: 16.000 FLUID OUNCES
STRENGTH: POVIDONE-IODINE EQUIVALENT TO 0.5 PERCENT AVAILABLE IODINE
Related Searches:
LIMBITROL 10-25
CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505010683545
NSN
6505-01-068-3545
LIMBITROL 10-25
CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505010683545
NSN
6505-01-068-3545
MFG
HOFFMANN-LA ROCHE INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS AMITRIPTYLINE HYDROCHLORIDE ACTIVE INGREDIENT AND 10.000 MILLIGRAMS CHLORDIAZEPOXIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
